Deliverables (DL) in Lot 1- EQA for  Sal mo n e l a  DL1: A letter of invitation  to participate in the EQA scheme within one month after the  agreed start of the EQA. The letter should include information about the EQA timetable,  methods to be used and how the results will be reported.  DL2: A list of laboratories  of participants that signed up to take part of the EQA scheme.  ECDC has the right to review the list of invited/participating laboratories and make changes  where needed. The list should be provided within two months after the agreed start of the  EQA.  DL3: A detailed project plan  for the full EQA exercise with tasks, timelines, methods to  be used and an overview of the bacterial strains and sequences to be included in the EQA  and the rationale for selecting them. The plan with detailed project schedule should be  approved by ECDC before execution. Preparation and distribution of test strains/sequences  should be done within 4 months after the agreed start of the EQA.  DL4: Individual evaluation reports  about the performance of each participating  laboratory on each method to allow the participant to rate their performance against the  expected results. The feedback reports must include recommendations for improvements  and troubleshooting advice (if needed), and should be provided within two months after  collecting the results from participating laboratories. Copies of the individual evaluation  reports should be provided to ECDC.  DL5: ECDC certificates  provided to the participating laboratories within two months after  collecting the EQA results using the ECDC template and following approval by ECDC.  DL6: A participant feedback survey  administered within 2 to 4 weeks after collecting  the results from participating laboratories. The results must be provided to ECDC and  aggregated results included and discussed in the comprehensive EQA report (DL 7).  DL7:  The collated raw data of the EQA exercise (information and results from participating  laboratories) in an  electronic database . This data should be provided to ECDC within six  months after collecting the results from participating laboratories.  DL8: A comprehensive EQA report  per EQA scheme and per pathogen on the outcomes  of the EQA exercise using ECDC’s template. This report should identify common problems (if  any) and discuss potential reasons for any diverging results, putting the results in the  overall context and make recommendations for improving the laboratory performance at the  EU-level. The report should summarise the results of the participating laboratories and  provide pseudonymous individual data. The report should be provided to ECDC within six  months after collecting the results from participating laboratories. The report will be  published on ECDC website after internal clearance. DL9: A PowerPoint presentation  summarising the EQA results in a clear and concise  way with graphics that aid in the interpretation of the results provided to ECDC within six  months after collecting the results from participating laboratories.  DL10 :  A final report  at the completion of the EQA summarising up all the activities during  a specific contract period including information about shipment of test strains, problems  encountered, performance and trouble-shooting services provided to the participating  laboratories not able to achieve acceptable level of performance.  Time frame:  The entire scheme will be a maximum of 12 months. 11 